Search research articles
Contact Us
Filters
Showing results (91-100 of 129) with videos related to
Page
of 13
Sort By:
The Journal of Sports Medicine and Physical Fitness
|
July 30, 2015
Improved end-stage high-intensity performance but similar glycemic responses after waxy barley starch ingestion compared to dextrose in type 1 diabetes
Benjamin J Gray, Rhydian Page, Daniel Turner, et al.
Diabetes, Obesity & Metabolism
|
May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
Lawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2019
Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
Subodh Verma, Stephen C Bain, Tea Monk Fries, et al.
Diabetes Care
|
July 21, 2018
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Chantal Mathieu, Paresh Dandona, Pieter Gillard, et al.
Diabetes, Obesity & Metabolism
|
July 10, 2020
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials
Subodh Verma, Stephen C Bain, Julie Broe Honoré, et al.
Diabetes, Obesity & Metabolism
|
October 8, 2025
Addressing the risk of ocular complications of GLP-1RAs; a multi-disciplinary expert consensus
Patrice Carter, Rafael Simó, Monica Lövestam-Adrian, et al.
Advances in Therapy
|
November 5, 2021
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
Marc Evans, Ruth D Lewis, Angharad R Morgan, et al.
Plos One
|
May 27, 2014
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial
Matthew D Campbell, Mark Walker, Michael I Trenell, et al.
Drugs
|
December 21, 2021
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
Marc Evans, Angharad R Morgan, Martin B Whyte, et al.
Journal of the American College of Cardiology
|
March 14, 2020
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Steven P Marso, Florian M M Baeres, Stephen C Bain, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 129) with videos related to
Sort By:
Page
of 13
The Journal of Sports Medicine and Physical Fitness
|
July 30, 2015
Improved end-stage high-intensity performance but similar glycemic responses after waxy barley starch ingestion compared to dextrose in type 1 diabetes
Benjamin J Gray, Rhydian Page, Daniel Turner, et al.
Diabetes, Obesity & Metabolism
|
May 7, 2020
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
Lawrence A Leiter, Stephen C Bain, Deepak L Bhatt, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2019
Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
Subodh Verma, Stephen C Bain, Tea Monk Fries, et al.
Diabetes Care
|
July 21, 2018
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Chantal Mathieu, Paresh Dandona, Pieter Gillard, et al.
Diabetes, Obesity & Metabolism
|
July 10, 2020
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials
Subodh Verma, Stephen C Bain, Julie Broe Honoré, et al.
Diabetes, Obesity & Metabolism
|
October 8, 2025
Addressing the risk of ocular complications of GLP-1RAs; a multi-disciplinary expert consensus
Patrice Carter, Rafael Simó, Monica Lövestam-Adrian, et al.
Advances in Therapy
|
November 5, 2021
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
Marc Evans, Ruth D Lewis, Angharad R Morgan, et al.
Plos One
|
May 27, 2014
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial
Matthew D Campbell, Mark Walker, Michael I Trenell, et al.
Drugs
|
December 21, 2021
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
Marc Evans, Angharad R Morgan, Martin B Whyte, et al.
Journal of the American College of Cardiology
|
March 14, 2020
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Steven P Marso, Florian M M Baeres, Stephen C Bain, et al.
Page
of 13